Molina Healthcare (NYSE:MOH) Upgraded at Wall Street Zen

by · The Markets Daily

Wall Street Zen upgraded shares of Molina Healthcare (NYSE:MOH – Free Report) from a sell rating to a hold rating in a report issued on Saturday,Wall Street Zen reports.

Several other analysts have also weighed in on MOH. Mizuho set a $255.00 price objective on Molina Healthcare in a report on Friday. Zacks Research lowered Molina Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, October 12th. Robert W. Baird set a $198.00 price target on shares of Molina Healthcare in a research report on Friday. Weiss Ratings upgraded shares of Molina Healthcare from a “sell (d)” rating to a “sell (d+)” rating in a research report on Wednesday, October 21st. Finally, Royal Bank Of Canada upped their price target on shares of Molina Healthcare from $218.00 to $222.00 and gave the company a “sector perform” rating in a report on Friday. Three investment analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $211.75.

Read Our Latest Report on Molina Healthcare

Molina Healthcare Price Performance

MOH opened at $204.95 on Friday. The company has a market capitalization of $10.70 billion, a P/E ratio of -213.48, a PEG ratio of 29.89 and a beta of 0.78. The company has a 50-day moving average of $200.74 and a 200-day moving average of $184.42. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.69 and a current ratio of 1.69. Molina Healthcare has a 1-year low of $121.06 and a 1-year high of $244.89.

Molina Healthcare (NYSE:MOH – Get Free Report) last released its earnings results on Wednesday, October 21st. The company reported $0.89 earnings per share for the quarter, beating the consensus estimate of $0.79 by $0.10. The firm had revenue of $11.08 billion during the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a negative net margin of 0.11% and a positive return on equity of 2.50%. The firm’s revenue for the quarter was down 3.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.84 earnings per share. Equities analysts expect that Molina Healthcare will post 5.30 EPS for the current fiscal year.

Institutional Trading of Molina Healthcare

Large investors have recently made changes to their positions in the business. BlackRock Inc. bought a new position in shares of Molina Healthcare in the 2nd quarter valued at about $1,503,052,000. Wellington Management Group LLP raised its stake in shares of Molina Healthcare by 11.9% during the second quarter. Wellington Management Group LLP now owns 1,267,207 shares of the company’s stock worth $289,810,000 after buying an additional 135,247 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Molina Healthcare by 23.7% during the first quarter. Dimensional Fund Advisors LP now owns 1,394,882 shares of the company’s stock worth $185,929,000 after buying an additional 267,121 shares during the last quarter. Manning & Napier Advisors LLC acquired a new position in Molina Healthcare in the second quarter valued at approximately $152,339,000. Finally, Bank of New York Mellon Corp acquired a new position in Molina Healthcare in the second quarter valued at approximately $86,138,000. Institutional investors own 98.50% of the company’s stock.

About Molina Healthcare

(Get Free Report)

Molina Healthcare, Inc is a managed-care company that provides health insurance and related services primarily through government-sponsored programs. Its offerings include Medicaid, Medicare, Medicare-Medicaid dual-eligible plans and health plans sold through government marketplaces under the Affordable Care Act.

The company’s services generally include medical care coordination, behavioral health support, pharmacy benefits and, depending on the plan and state, dental and vision benefits.

Recommended Stories